<DOC>
	<DOCNO>NCT01559779</DOCNO>
	<brief_summary>The study aim describe acute subacute change Roux-en-Y ( RYGB ) gastric bypass insulin secretion beta cell glucagon secretion alpha cell well stimulatory effect incretins pancreatic islet . RYGB bariatric procedure change gastrointestinal anatomy demonstrate cause remission type 2 diabetes shortly operation , significant weight loss . The altered transit nutrient gastrointestinal tract operation think play key role remission study show significant change secretion gut hormone , namely incretin hormone glucagon-like peptide-1 ( GLP-1 ) . However unknown whether secretory function pancreatic islet well stimulatory effect incretin hormone change postoperatively .</brief_summary>
	<brief_title>Effect Gastric Bypass Surgery Pancreatic Islets Incretin Function</brief_title>
	<detailed_description />
	<mesh_term>Incretins</mesh_term>
	<mesh_term>Gastric Inhibitory Polypeptide</mesh_term>
	<criteria>Normal glucose tolerance Age &gt; 18 year BMI &gt; 40 &gt; 35 combine hypertension obstructive sleep apnoea Caucasian Normal hemoglobinaemia Signed inform consent Major psychiatric disorder Alcohol drug abuse Major hearth pulmonary disease Previous major abdominal disease ( e.g . peritonitis , large hernia ) Pregnancy/lactation Treatment GLP1 analog</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Obesity</keyword>
	<keyword>Roux-en-Y gastric bypass</keyword>
	<keyword>Incretin hormone</keyword>
	<keyword>Beta cell function</keyword>
</DOC>